Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001318148-12-000229
Filing Date
2012-02-09
Accepted
2012-02-09 09:32:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 form.htm SC 13G 54850
2 GRAPHIC image_001.gif GRAPHIC 2863
  Complete submission text file 0001318148-12-000229.txt   60743
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 12584622
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address FEDERATED INVESTORS TOWER PITTSBURGH PA 15222
Business Address FEDERATED INVESTORS TOWER 5800 CORPORATE DR PITTSBURGH PA 15222 4122888141
FEDERATED INVESTORS INC /PA/ (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice